3,4-methylenedioxyamphetamine has been researched along with fenfluramine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 11 (61.11) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glennon, RA | 1 |
| Azmitia, EC; Berger, UV; Gu, XF | 1 |
| Culp, S; DeSouza, EB; Lehmann, J; Zaczek, R | 1 |
| Black, CK; Schmidt, CJ; Taylor, VL | 1 |
| Evans, SM; Johanson, CE; Zacny, JP | 1 |
| Peroutka, SJ; Wagner, J | 1 |
| Cabrera, T; Hamilton, ME; Hata, N; Lorens, SA | 1 |
| Schechter, MD | 1 |
| Colado, MI; Green, AR; Murray, TK | 1 |
| Rudnick, G; Schuldiner, S; Steiner-Mordoch, S; Wall, SC; Yelin, R | 1 |
| Azmitia, EC; Kramer, K; Whitaker-Azmitia, PM | 1 |
| Miller, DB; O'Callaghan, JP | 1 |
| Adler, L; Huether, G; Poeggeler, B; Rüther, E | 1 |
| Kehne, JH; McCloskey, TC; Padich, RA; Schmidt, CJ; Taylor, VL | 1 |
| Connor, TJ; Kelly, JP; Leonard, BE | 1 |
| Blough, B; Glennon, RA; Grande-Allen, KJ; Hufeisen, SJ; Roth, BL; Rothman, RB; Setola, V; Vesely, I | 1 |
| Belzung, C; Bodard, S; Chalon, S; Galineau, L; Guilloteau, D; Kodas, E | 1 |
| Ehrman, LA; Gudelsky, GA; Schaefer, TL; Vorhees, CV; Williams, MT | 1 |
18 other study(ies) available for 3,4-methylenedioxyamphetamine and fenfluramine
| Article | Year |
|---|---|
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
Topics: Animals; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Dopamine; Drug Discovery; Hallucinogens; Humans; Illicit Drugs; Norepinephrine; Phenethylamines; Psychotropic Drugs; Receptors, Serotonin; Serotonin | 2017 |
The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Calcium; Cocaine; Fenfluramine; Fluoxetine; In Vitro Techniques; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Synaptosomes | 1992 |
Regional distribution to recovery of 5-HT levels after administration of "atrophins" MDMA and D,L-fenfluramine. Stereospecificity and comparison with 5,7-dihydroxytryptamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; 5,7-Dihydroxytryptamine; Animals; Atrophy; Brain; Cerebral Ventricles; Designer Drugs; Dopamine; Fenfluramine; Homovanillic Acid; Hydroxyindoleacetic Acid; Injections, Intraventricular; Male; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Organ Specificity; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin; Stereoisomerism | 1992 |
L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Chemistry; Cerebral Cortex; Corpus Striatum; Dopamine; Drug Synergism; Fenfluramine; Hippocampus; Levodopa; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration; Nerve Endings; Nervous System Diseases; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Serotonin | 1991 |
Three-choice discrimination among (+)-amphetamine, fenfluramine and saline in pigeons.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Columbidae; Discrimination, Psychological; Female; Fenfluramine; Generalization, Stimulus; N-Methyl-3,4-methylenedioxyamphetamine; Sodium Chloride | 1990 |
Neurochemistry and neurotoxicity of substituted amphetamines.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Designer Drugs; Fenfluramine; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Endings; Paroxetine; Piperidines; Rats; Receptors, Serotonin; Serotonin | 1990 |
Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
Topics: 3,4-Methylenedioxyamphetamine; 5,7-Dihydroxytryptamine; Amphetamines; Animals; Arousal; Behavior, Animal; Brain; Designer Drugs; Dihydroxytryptamines; Fenfluramine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin | 1989 |
Discriminative profile of MDMA.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Apomorphine; Discrimination Learning; Dose-Response Relationship, Drug; Female; Fenfluramine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Receptors, Dopamine; Receptors, Serotonin | 1986 |
5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Behavior, Animal; Body Temperature; Brain Chemistry; Cerebral Cortex; Chlormethiazole; Dizocilpine Maleate; Fenfluramine; Hippocampus; Hydroxyindoleacetic Acid; Male; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Rats; Serotonin | 1993 |
Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Blood Platelets; Carrier Proteins; Cattle; Cell Membrane; Chromaffin Granules; Fenfluramine; Humans; In Vitro Techniques; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; p-Chloroamphetamine; Reserpine; Serotonin; Serotonin Plasma Membrane Transport Proteins | 1993 |
In vitro release of [3H]5-hydroxytryptamine from fetal and maternal brain by drugs of abuse.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain; Brain Chemistry; Cocaine; Designer Drugs; Female; Fenfluramine; In Vitro Techniques; Maternal-Fetal Exchange; N-Methyl-3,4-methylenedioxyamphetamine; Potassium Chloride; Pregnancy; Rats; Rats, Sprague-Dawley; Serotonin; Substance-Related Disorders; Synaptosomes | 1994 |
The interactions of MK-801 with the amphetamine analogues D-methamphetamine (D-METH), 3,4-methylenedioxymethamphetamine (D-MDMA) or D-fenfluramine (D-FEN): neural damage and neural protection.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Biomarkers; Brain; Cerebral Cortex; Corpus Striatum; Dizocilpine Maleate; Female; Fenfluramine; Glial Fibrillary Acidic Protein; Hippocampus; Methamphetamine; Mice; Mice, Inbred C57BL; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Neurotoxins | 1993 |
Effects of indirectly acting 5-HT receptor agonists on circulating melatonin levels in rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Fenfluramine; Fluoxetine; Injections, Intraperitoneal; Male; Melatonin; Pargyline; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin Receptor Agonists; Tryptophan | 1993 |
5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Cerebral Cortex; Dose-Response Relationship, Drug; Fenfluramine; Male; p-Chloroamphetamine; Rats; Rats, Wistar; Reflex, Startle; Serotonin; Serotonin Agents | 1996 |
An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Concanavalin A; Cytokines; Female; Fenfluramine; Immunity; Leukocyte Count; Lipopolysaccharides; Lymphocyte Activation; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin Agents | 2000 |
3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Cell Division; Cells, Cultured; COS Cells; Fenfluramine; Heart Valve Diseases; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Norfenfluramine; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin; Serotonin Agents | 2003 |
Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Adrenergic Uptake Inhibitors; Age Factors; Analysis of Variance; Animals; Animals, Newborn; Autoradiography; Brain; Brain Chemistry; Dopamine; Embryo, Mammalian; Female; Fenfluramine; Hallucinogens; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Membrane Transport Proteins; Microdialysis; Nortropanes; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Sex Factors; Time Factors; Tyramine | 2005 |
Comparison of monoamine and corticosterone levels 24 h following (+)methamphetamine, (+/-)3,4-methylenedioxymethamphetamine, cocaine, (+)fenfluramine or (+/-)methylphenidate administration in the neonatal rat.
Topics: 3,4-Methylenedioxyamphetamine; Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Biogenic Monoamines; Body Weight; Brain Chemistry; Chromatography, High Pressure Liquid; Cocaine; Corpus Striatum; Corticosterone; Electrochemistry; Female; Fenfluramine; Hippocampus; Immunoenzyme Techniques; Male; Maze Learning; Methamphetamine; Methylphenidate; Neurotransmitter Uptake Inhibitors; Pregnancy; Rats; Rats, Sprague-Dawley | 2006 |